Bristol-Myers director Gerald Storch not seeking re-election; board size set to ten

BRISTOL MYERS SQUIBB CO

Gerald Storch notified the Board on March 13, 2024, that he will not stand for re-election at the 2024 Annual Meeting.
Board set the number of directors at ten, effective after the Annual Meeting expected on May 7, 2024.
Storch's departure is voluntary; no replacement has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Gerald Storch

Director

BMY · BRISTOL MYERS SQUIBB CO

Effective: 2024-05-07
Filed: March 18, 2024, 7:59 PM ET

On March 13, 2024, Mr. Gerald Storch notified the Board of Directors (the "Board") of Bristol-Myers Squibb Company (the "Company") that he will not stand for re-election to the Board of the Company at the 2024 Annual Meeting of Shareholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Gerald Storch departed as Director at BRISTOL MYERS SQUIBB CO.

Action: will not stand for re-election
Role: Director

Exact text from the filing

On March 13, 2024, Mr. Gerald Storch notified the Board of Directors (the "Board") of Bristol-Myers Squibb Company (the "Company") that he will not stand for re-election to the Board of the Company at the 2024 Annual Meeting of Shareholders.

View on SEC.gov

BRISTOL MYERS SQUIBB CO filing history →

Source: SEC EDGAR

accession 0001140361-24-013978

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.